drugset / Trial / NCT02705989
Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety profile, tolerability, pharmacokinetics, and pharmacodynamics following single and multiple ascending oral doses of BMS-986195 in healthy subjects, and to assess the relative bioavailability of two formulations of BMS-986195 with or without food.
Timeline
- Start
- 2016-08-18
- Primary completion
- 2017-08-16
- Completion
- 2017-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Branebrutinib | Small molecule | — | Oral |